光正眼科
(002524)
| 流通市值：22.52亿 | | | 总市值：22.97亿 |
| 流通股本：5.08亿 | | | 总股本：5.18亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 208,167,536.89 | 892,842,271.65 | 698,778,682.45 | 481,903,187.33 |
| 营业收入 | 208,167,536.89 | 892,842,271.65 | 698,778,682.45 | 481,903,187.33 |
| 二、营业总成本 | 210,803,000.59 | 937,439,817.91 | 722,117,114.93 | 487,190,883.26 |
| 营业成本 | 129,879,287.6 | 563,895,680.2 | 440,914,261.56 | 298,696,257.61 |
| 税金及附加 | 1,364,467.6 | 4,275,266.56 | 3,433,389.64 | 2,011,958.34 |
| 销售费用 | 40,476,044.87 | 187,697,083.27 | 143,713,024.94 | 96,398,844.45 |
| 管理费用 | 29,204,583.3 | 138,838,602.42 | 103,513,659.62 | 69,198,214.19 |
| 研发费用 | 625,006 | 3,580,360.61 | 1,877,901.94 | 1,252,903.94 |
| 财务费用 | 9,253,611.22 | 39,152,824.85 | 28,664,877.23 | 19,632,704.73 |
| 其中:利息费用 | 8,982,567.81 | 38,379,206.64 | 28,335,160.19 | 18,959,088.62 |
| 其中:利息收入 | 107,217.96 | 636,631.11 | 938,026.45 | 185,358.8 |
| 加:投资收益 | 2,587,132.19 | 14,768,363.72 | 8,303,343.84 | 6,578,568.6 |
| 资产处置收益 | 1,397.07 | 5,020,865.74 | 4,944,019.66 | 4,931,136.83 |
| 资产减值损失(新) | 374,869.55 | -133,155,370.85 | -253,136.45 | -243,701.33 |
| 信用减值损失(新) | 1,201,040.93 | -3,408,297.1 | -1,487,525.86 | 436,175.27 |
| 其他收益 | 286,291.34 | 4,890,451.74 | 1,044,660.73 | 370,241.85 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 1,815,267.38 | -156,481,533.01 | -10,787,070.56 | 6,784,725.29 |
| 加:营业外收入 | 76,022.67 | 567,090.96 | 250,173.38 | 224,327.27 |
| 减:营业外支出 | 654,737.54 | 5,172,305.87 | 4,802,468.4 | 2,995,320.36 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 1,236,552.51 | -161,086,747.92 | -15,339,365.58 | 4,013,732.2 |
| 减:所得税费用 | 495,171.23 | 13,890,014.65 | 4,945,101.06 | 3,120,239.9 |
| 六、净利润 | 741,381.28 | -174,976,762.57 | -20,284,466.64 | 893,492.3 |
| 持续经营净利润 | 741,381.28 | -174,976,762.57 | -20,284,466.64 | 893,492.3 |
| 归属于母公司股东的净利润 | 573,756.72 | -174,653,435.06 | -20,808,633.35 | 1,273,940.73 |
| 少数股东损益 | 167,624.56 | -323,327.51 | 524,166.71 | -380,448.43 |
| (一)基本每股收益 | 0 | -0.34 | -0.04 | 0 |
| (二)稀释每股收益 | 0 | -0.34 | -0.04 | 0 |
| 八、其他综合收益 | - | 408,800 | - | - |
| 归属于母公司股东的其他综合收益 | - | 408,800 | - | - |
| 九、综合收益总额 | 741,381.28 | -174,567,962.57 | -20,284,466.64 | 893,492.3 |
| 归属于母公司股东的综合收益总额 | 573,756.72 | -174,244,635.06 | -20,808,633.35 | 1,273,940.73 |
| 归属于少数股东的综合收益总额 | 167,624.56 | -323,327.51 | 524,166.71 | -380,448.43 |
| 公告日期 | 2025-04-28 | 2025-04-24 | 2024-10-25 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |